Steric inhibition of cytoplasmic dynein and kinesin motility by MAP2
Abstract
Using several in vitro motility assays, we found that motility driven by the microtubule (MT) motors, kinesin and cytoplasmic dynein, could be inhibited by MAP2 but not by tau protein or the MT-binding proteolytic fragment of MAP2. In MT gliding assays, even the presence of one MAP2 molecule per sixty-nine tubulin dimers caused an inhibition of about 75% of MT motility at low concentrations of both motors. The percent inhibition of motility decreased with increasing concentration of either motor, suggesting that the inhibition was the result of competition for access to the MT surface. The decrease in the number of moving MTs with MAP2 was correlated with an increase in the frequency of release of moving MTs from the motor-coated glass. In assays of in vitro vesicular organelle motility and formation of ER networks, the presence of MAP2 inhibited small vesicle movements and to a lesser extent ER network formation. To determine if competition for specific sites on the MT or coating of the MT surface inhibited motility, we used tau protein and the chymotryptic MT-binding fragments of MAP2 to coat MTs. No inhibition was observed and there was even an increase in the number of attached and moving MTs in the gliding assay with tau-coated MTs. Because MAP2, tau and the chymotryptic MT-binding fragments of MAP2 bind to the same domain on tubulin, masking of the MT surface sites does not appear responsible for the inhibition of motility by MAP2. Rather, we suggest that the sidearm of…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MAP2 has been shown to block the path of kinesin motors in in vitro assays.
“MAP2 has been shown to block the path of kinesin motors in in vitro assays (46, 47, 48, 49, 50).”
From Active transport by cytoplasmic dynein sustains dendritic MAP2 localization in developing neurons (2026) · cites this paper as [47]
Cites
De Camilli, P., Miller, P. E., Navone, F., Theurkauf, W. E., & Vallee, R. B. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90194-5 · Cited by 381 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Single-molecule investigation of the interference between kinesin, tau and MAP2c
Seitz, A., Kojima, H., Oiwa, K., Mandelkow, E.-M., Song, Y.-H., & Mandelkow, E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf503 · Cited by 257 · see citing works
Serotonin 5-HT1A Receptors Regulate NMDA Receptor Channels through a Microtubule-Dependent Mechanism
Yuen, E. Y. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1187-05.2005 · Cited by 225 · see citing works
Mechanisms of trafficking in axons and dendrites: implications for development and neurodegeneration
Sheetz, M. P., Pfister, K. K., Bulinski, J. C., & Cotman, C. W. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00021-5 · Cited by 55 · see citing works
Self-citationActive transport by cytoplasmic dynein sustains dendritic MAP2 localization in developing neurons
Yonemura, Y., Sakai, Y., Nakata, R., Hagita-Tatsumoto, A., Miyasaka, T., & Misonou, H. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113407
- Authors
- Lopez, L. A., & Sheetz, M. P.
- Affiliations
- Duke Medical Center (US)
- Corresponding author
- Sheetz, Michael P.
- ORCID
- Sheetz, Michael P.
- Venue
- Cell Motility
- Publisher
- Wiley
- Published
- 1993-01
- Volume
- 24
- Issue
- 1
- Pages
- 1-16
- ISSN
- 0886-1544 (ISSN-L)
- OpenAlex
- W2039348923
- Cited by
- 115
- References
- 1
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 3 · 2020: 3 · 2019: 4 · 2017: 3 · 2016: 5 · 2014: 2 · 2013: 2 · 2012: 1
- FWCI
- 3.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cell Motility and the Cytoskeleton (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ns023345-17, 5r01gm034775-10)
- National Institute of General Medical Sciences (GM34775)
- National Institute of Neurological Disorders and Stroke (NS23345)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- MAP2, cytoplasmic dynein, kinesin, microtubule motor proteins, steric inhibition, microtubule gliding, tau protein, vesicle motility, cell polarity
- MeSH terms
- Animals, Binding, Competitive, Biological Transport, Cattle, Cytoplasm, Dyneins, Endoplasmic Reticulum, Microtubule-Associated Proteins, Microtubules, Movement, Protein Conformation, Organelles, Kinesins, tau Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review